Loading...
XBRU
BTLS
Market cap155mUSD
May 27, Last price  
3.66EUR
1D
9.25%
1Q
18.06%
IPO
-52.34%
Name

Biotalys NV

Chart & Performance

D1W1MN
XBRU:BTLS chart
No data to show
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
0k
Net income
-21m
L-9.77%
-7,670,000-10,750,000-16,929,000-22,731,000-20,510,000
CFO
-18m
L-9.00%
-8,224,000-9,533,000-16,754,000-20,091,000-18,283,000

Profile

Biotalys NV, an agricultural technology company, discovers and develops novel biological products for the protection of food and crops. It primarily develops biofungicides, bioinsecticides, and biobactericides. The company was formerly known as Agrosavfe NV. Biotalys NV was incorporated in 2013 and is headquartered in Gent, Belgium.
URL
https://biotalys.com/
IPO date
Jul 02, 2021
Employees
Domiciled in
BE
Incorporated in
BE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
23,559
25,480
Unusual Expense (Income)
NOPBT
(23,559)
(25,480)
NOPBT Margin
Operating Taxes
56
(38)
Tax Rate
NOPAT
(23,615)
(25,442)
Net income
(20,510)
-9.77%
(22,731)
34.27%
Dividends
Dividend yield
Proceeds from repurchase of equity
6,962
236
BB yield
-4.72%
-0.11%
Debt
Debt current
1,163
Long-term debt
3,185
5,338
Deferred revenue
Other long-term liabilities
5,467
105
Net debt
(18,385)
(27,595)
Cash flow
Cash from operating activities
(18,283)
(20,091)
CAPEX
(341)
(707)
Cash from investing activities
233
(684)
Cash from financing activities
5,530
(1,242)
FCF
(23,046)
(25,154)
Balance
Cash
21,570
34,096
Long term investments
Excess cash
21,570
34,096
Stockholders' equity
10,081
24,887
Invested Capital
20,955
19,833
ROIC
ROCE
EV
Common stock shares outstanding
31,587
30,898
Price
4.67
-31.32%
6.80
-4.49%
Market cap
147,512
-29.79%
210,108
91.28%
EV
129,127
182,513
EBITDA
(21,775)
(23,905)
EV/EBITDA
Interest
247
Interest/NOPBT